Laboratory Animal Models in Veterinary Virology: Inoculation Protocols, Pathogenesis, and Diagnostic Utility

1. Introduction: The Indispensable Role of Animal Models

Despite the widespread adoption of in vitro cell culture systems and molecular detection platforms (e.g., reverse-transcription quantitative PCR, next-generation sequencing), laboratory animal models remain a cornerstone of veterinary virology research and diagnostics. Cell lines, while useful for virus isolation and titration, fail to recapitulate complex host-pathogen interactions that drive neuropathogenesis, systemic viral spread, and the integrated immune response cascade. For example, the neurotropic behavior of Rabies Lyssavirus requires an intact blood-brain barrier and axonal transport mechanisms that cannot be replicated in monolayer cultures [1]. Similarly, the vesicular lesions of Foot And Mouth Disease Virus (FMDV) depend on tissue tropism and local inflammatory responses only observable in vivo [2].

This article provides a systematic technical reference for the five most common laboratory animal species used in veterinary virology: suckling mice, adult mice, rabbits, guinea pigs, and hamsters. For each model, detailed inoculation routes, biophysical mechanisms, clinical monitoring parameters, and postmortem tissue collection procedures are described. Ethical frameworks governing animal use, including the Three Rs (Replacement, Reduction, Refinement), biosafety level (BSL) containment, and Institutional Animal Care and Use Committee (IACUC) oversight, are integrated throughout.

2. Ethical and Regulatory Frameworks

All animal experiments must adhere to the Three Rs as defined by Russell and Burch (1959). Replacement refers to substituting conscious higher animals with in vitro systems or invertebrates where possible. Reduction minimizes the number of animals per group while maintaining statistical power. Refinement optimizes housing, anesthesia, and analgesia to minimize pain and distress. In veterinary virology, BSL-2 containment is sufficient for low-risk agents (e.g., Murine Norovirus), while BSL-3 is required for high-consequence pathogens such as Rift Valley Fever Virus and Eastern Equine Encephalitis Virus. BSL-3-Ag (agricultural) adds additional containment for transboundary animal diseases like FMDV and Classical Swine Fever Virus. All protocols require prior IACUC approval, including justification of animal numbers, humane endpoints, and euthanasia methods (typically carbon dioxide inhalation or pentobarbital overdose for rodents).

3. Suckling Mice (Mus musculus, 24-48 hours old)

Suckling mice (1-2 days of age) possess an immature innate immune system characterized by low natural killer cell activity, deficient complement function, and reduced type I interferon responses. This renders them exquisitely susceptible to many neurotropic and viscerotropic viruses that are avirulent in adult mice. The most common inoculation route is intracerebral (IC), used for the isolation of arboviruses such as Venezuelan Equine Encephalitis Virus, Western Equine Encephalitis Virus, and Louping Ill virus. Intraperitoneal (IP) and subcutaneous (SC) routes are also employed for viruses that replicate systemically.

3.1 Intracerebral Inoculation Procedure

1. Anesthesia: The pup is placed on a sterile gauze pad over crushed ice for 2-3 minutes until immobile. This induces hypothermia-based anesthesia, which is reversible and does not interfere with viral replication.
2. Site Preparation: The dorsal aspect of the cranium is swabbed with 70% ethanol or chlorhexidine.
3. Needle and Volume: A 30-gauge hypodermic needle attached to a 0.3 mL insulin syringe is used. The needle is inserted at a point equidistant between the ear base and the eye, approximately 2 mm off the midline, angled 45 degrees posteriorly. The tip penetrates the skull (a slight loss of resistance is felt) to a depth of 2-3 mm. Maximum inoculum volume is 0.02 mL (20 µL).
4. Post-Inoculation: The pup is warmed under a heat lamp (not exceeding 37°C) and returned to the dam when fully recovered. Littermates are identified by toe-clip or tattoo.

3.2 Pathogenesis and Clinical Signs

Following IC inoculation with Rabies Lyssavirus, the virus replicates locally in neurons, then spreads trans-synaptically throughout the central nervous system. Clinical signs appear 5-14 days post-inoculation and include progressive paralysis of the hind limbs, tremors, ataxia, and terminal opisthotonos. For alphaviruses (Eastern, Western, Venezuelan equine encephalitis), death occurs 2-5 days post-inoculation with central nervous system involvement characterized by spongiform degeneration of the neuropil. Suckling mice inoculated IP with Rift Valley Fever Virus develop fulminant hepatic necrosis and die within 72 hours.

3.3 Tissue Collection

Moribund mice are euthanized by decapitation (pups) or pentobarbital overdose. Brains are harvested aseptically: the cranium is opened with sterile scissors, the brain lifted with forceps, and placed into either 10% neutral buffered formalin for histopathology or sterile phosphate-buffered saline (PBS) for virus isolation. For systemic virus (e.g., Rift Valley Fever), liver, spleen, and blood (via cardiac puncture using a 0.5 mL syringe with 27-gauge needle) are also collected.

4. Adult Mice

Adult mice (3-8 weeks old) have a fully functional immune system and are used to model viruses that cause respiratory, enteric, or systemic disease. Common inoculation routes include intranasal (IN), footpad (FP), and intravenous (IV, lateral tail vein).

4.1 Intranasal Inoculation

1. Anesthesia: The mouse is placed in an induction chamber with 3-5% isoflurane in oxygen until recumbent. A face mask is fitted to maintain anesthesia at 1.5-2%.
2. Procedure: The mouse is held in dorsal recumbency. A micropipette fitted with a sterile 200 µL tip is used to slowly deposit 20-50 µL of viral inoculum (e.g., Sendai Virus or Murine Norovirus) into the nares, alternating nostrils. The mouse is kept in this position for 30 seconds to allow aspiration.
3. Clinical Monitoring: Respiratory signs include nasal discharge, increased respiratory effort, and audible rales. Weight loss is quantitated daily; >20% weight loss indicates a humane endpoint.

4.2 Footpad Inoculation

Used for Ectromelia Virus (mousepox) and vesicular viruses. The plantar surface of the hind foot is cleaned with 70% ethanol. A 27-gauge needle is used to inject 0.05 mL of virus suspension intradermally. Primary swelling of the footpad occurs within 3-5 days, followed by necrosis and sloughing. Systemic spread is monitored by tail lesions, conjunctivitis, and splenomegaly.

4.3 Intravenous Inoculation (Tail Vein)

The mouse is restrained in a clear plastic tube with the tail exposed. The tail is warmed under a 60 W incandescent lamp for 2 minutes to dilate the lateral veins. A 27-gauge butterfly needle is inserted into the lateral tail vein, bevel up, at a 15-degree angle. Blood flashback confirms venous access. Maximum volume is 0.2 mL. This route is used for Lymphocytic Choriomeningitis Virus (LCMV) to induce systemic infection.

5. Rabbits (Oryctolagus cuniculus)

Rabbits are historically significant in virology: Louis Pasteur used them for rabies vaccine development by serial passage of spinal cord tissue. Today, rabbits serve as models for Myxoma Virus, Rabbit Hemorrhagic Disease Virus 2 (RHDV), and ocular infections with Equine Herpesvirus 1.

5.1 Corneal Inoculation (Equine Herpesvirus Model)

1. Anesthesia: Ketamine (35 mg/kg) and xylazine (5 mg/kg) intramuscularly. Topical 0.5% proparacaine is applied to the cornea.
2. Procedure: A 25-gauge needle is used to scarify the cornea in a cross-hatch pattern (3-4 scratches). Then, 0.1 mL of viral suspension (≥10^5 TCID50/mL) is instilled onto the scarified cornea. The eyelids are held closed for 30 seconds.
3. Monitoring: Keratitis, conjunctivitis, and corneal ulceration appear within 48-72 hours. Anterior chamber involvement (uveitis) indicates neuroinvasion.

5.2 Rabbit Hemorrhagic Disease Virus Model

RHDV is a calicivirus causing acute hepatitis and disseminated intravascular coagulation in rabbits. Inoculation is typically intramuscular (IM) or SC with 0.5 mL of liver homogenate filtrate. Clinical signs include fever (≥40°C), depression, and epistaxis within 24-48 hours. Necropsy reveals pale, friable liver with centrilobular necrosis.

5.3 Rabies Virus Model (Historical)

Unvaccinated rabbits are inoculated intracerebrally (0.1 mL, 27-gauge needle) with fixed rabies virus (Pasteur strain). After a 6-10 day incubation period, progressive paralysis (starting in the inoculated limb) and terminal coma develop. The spinal cord is harvested for vaccine preparation or titration.

6. Guinea Pigs (Cavia porcellus)

Guinea pigs are the gold-standard model for FMDV vesicle development and are also used for Guinea Pig Cytomegalovirus and rabies.

6.1 Plantar Pad Inoculation (Foot-and-Mouth Disease Virus)

1. Anesthesia: Ketamine (40 mg/kg) and xylazine (5 mg/kg) intramuscularly.
2. Procedure: The plantar surface of the hind foot is cleaned with 70% ethanol. A 25-gauge needle is used to make a small scratch (0.5 cm) in the epidermis, and then 0.2 mL of virus suspension (derived from a bovine tongue epithelial suspension) is rubbed into the scarified area.
3. Clinical Monitoring: Primary vesicles appear at the inoculation site within 24-48 hours. Secondary vesicles develop on the tongue, snout, and other footpads by 72-96 hours. The animal shows lameness, hypersalivation, and fever (≥40°C). This model recapitulates natural FMDV pathogenesis in livestock.
4. Tissue Collection: Vesicular fluid and epithelial flaps are harvested aseptically into 50% glycerol-PBS for RT-PCR or virus isolation.

7. Hamsters (Mesocricetus auratus)

Hamsters are uniquely susceptible to viruses that produce vascular pathology and encephalitis. They are models for Hamster Parvovirus, Hamster Polyomavirus, and equine influenza respiratory disease.

7.1 Intracranial Inoculation for Encephalitis

Hamsters (3-4 weeks old) are anesthetized with isoflurane. A 27-gauge needle is inserted into the right cerebral hemisphere (midpoint between eye and ear, 4 mm deep). Volume: 0.05 mL. This route induces fatal encephalitis with Hamster Polyomavirus within 10-14 days. Clinical signs include hunched posture, circling, and seizures.

7.2 Intranasal Inoculation for Respiratory Models

Hamsters are used for Equine Influenza A Virus because they develop reproducible bronchiolitis and interstitial pneumonia without prior adaptation. The hamster is lightly anesthetized (ketamine/xylazine), and 0.1 mL of virus is instilled into the nares (same procedure as adult mice). Maximal viral titers in lung homogenates occur at 3-4 days post-inoculation.

8. Comprehensive Comparative Table

9. Safety Triage, Inoculation, and Monitoring Workflow

flowchart TD
    A[Study Proposal], > B{IACUC Review}
    B, >|Approved| C[Animal Procurement]
    B, >|Rejected| D[Revise Protocol]
    C, > E[Quarantine & Acclimation 7 days]
    E, > F[BSL Assignment: BSL-2, BSL-3, or BSL-3-Ag]
    F, > G[Anesthesia Induction]
    G, > H[Inoculation: Route-specific procedure]
    H, > I[Post-inoculation Recovery under heat/oxygen]
    I, > J[Clinical Monitoring 2x/day]
    J, > K{Endpoint Criteria Met?}
    K, >|Yes| L[Euthanasia & Necropsy]
    K, >|No| M[Continue Monitoring]
    M, > J
    L, > N[Tissue Collection for PCR, VI, Histo]
    N, > O[Data Analysis & Reporting]

10. Biophysical Mechanisms and Clinical Sign Correlation

For neurotropic viruses, the dose deposited intracranially determines the local virus concentration at the injection site. Once inside the brain parenchyma, virions undergo retrograde or anterograde axonal transport. The incubation period is inversely proportional to the inoculum titer. For example, IC inoculation of rabies virus at 10^3 LD50 results in a mean incubation of 10 days, whereas 10^6 LD50 reduces incubation to 5 days [3]. The clinical sign of hindlimb paralysis reflects viral involvement of the lumbar spinal cord motor neurons.

For the FMDV guinea pig plantar pad model, the scarification disrupts the stratum corneum, allowing virions to bind to integrin receptors on basal keratinocytes. Replication in the epithelium triggers vesicle formation through intraepithelial edema and necrosis. The resulting vesicle contains high titers of infectious virus (up to 10^8 TCID50/mL) [4].

For Myxoma Virus in rabbits, intradermal inoculation leads to local replication in Langerhans cells, then dissemination to regional lymph nodes. Systemic spread produces secondary skin lesions (myxomas) and immunosuppression due to depletion of T and B lymphocytes in the spleen and lymph nodes. Clinical signs include blepharoconjunctivitis, ear drop, and subcutaneous swellings [5].

11. Conclusion

Laboratory animal models remain essential for understanding the pathophysiology of veterinary viruses, testing vaccine efficacy, and isolating field strains that fail to grow in cell culture. Researchers must select the appropriate species, age, inoculation route, and volume based on the virus's known tropism and pathogenesis. Strict adherence to the Three Rs and IACUC protocols ensures humane and reproducible science. The integration of molecular diagnostics with animal models (e.g., RT-PCR of brain homogenate from a Rabies-Lyssavirus-infected suckling mouse) provides definitive confirmation of viral etiology.

--

References

1. Dietzschold B, Schnell M, Koprowski H. Pathogenesis of rabies. Curr Top Microbiol Immunol. 2005;292:45-56.
2. Arzt J, Baxt B, Grubman MJ, et al. The pathogenesis of foot-and-mouth disease II: viral pathways in swine, small ruminants, and wildlife. Transbound Emerg Dis. 2011;58(4):305-326.
3. Jackson AC. Rabies virus pathogenesis: an update. Future Virol. 2011;6(1):97-112.
4. OIE (World Organisation for Animal Health). Foot and Mouth Disease. In: OIE Manual of Diagnostic Tests and Vaccines for Terrestrial Animals. 12th ed. Paris: OIE; 2023. Chapter 3.1.8.
5. Kerr PJ, Liu J, Cattadori I, et al. Myxoma virus and the Leporipoxviruses: an evolutionary paradigm. Viruses. 2015;7(3):1020-1061.
6. Russell WMS, Burch RL. The Principles of Humane Experimental Technique. London: Methuen; 1959.
7. Institute for Laboratory Animal Research. Guide for the Care and Use of Laboratory Animals. 8th ed. Washington, DC: National Academies Press; 2011.
8. Fenner F, Bachmann PA, Gibbs EPJ, et al. Veterinary Virology. 3rd ed. San Diego: Academic Press; 2011. (Chapters on laboratory animal inoculation techniques).
9. Wang LF, Crameri G, Rootes CL, et al. A mouse model for equine influenza virus infection. Vet Microbiol. 2002;87(4):291-302.
10. Barthold SW, Beck DS, Smith AL. Mouse hepatitis virus neuropathogenesis: the critical role of the host immune system. Lab Anim Sci. 1993;43(1):27-33.